Navigation Links
Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
Date:12/9/2008

GREAT NECK, N.Y., Dec. 9 /PRNewswire/ --Scarguard Labs, LLC, a closely held company specializing in the treatment of scars and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, announced it has agreements in place with Publix Supermarkets and McKesson Drugs to carry Scarguard products.

"These are very positive developments for Scarguard," said CEO Joel Studin. "McKesson is the largest drug wholesaler in the U.S., with more than 20 distribution centers across the country. Publix is the fourth largest grocery store chain in the U.S., and caters to a high-end clientele through its 450 stores across the Southeast.

"The McKesson agreement complements our existing agreements with Amerisource Bergen and Cardinal Health, and means that we have agreements with the three largest pharmaceutical distributors. This will give our products enormous visibility to retail customers across the country and with large independent drugstores chains in particular. The agreement immediately placed our products in McKesson's two largest retailers, and as a result, we have seen at least a 15% increase in the dollar volume of our sales.

"The Publix clientele is precisely the target market for Scarguard products," continued Studin. "It has been a long time goal of ours to reach an agreement with them. Eventually Publix came to believe that our products are the most efficacious of the category and saw our successes in other food chains such as ShopRite and Pathmark. We consider this agreement to be a highlight of our strategy to increase the retail presence for our products by expanding our presence in other channels."

About Scarguard Labs, LLC

Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors and major grocery chains throughout the United States. We have multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development For more information, please visit our website at www.scarguard.com.

    Company Contact:                                  Investor Relations:
    Richard E. Pino                                   John McNamara
    Chief Financial Officer/Investor Relations        Cameron Associates
    Scarguard Labs, LLC                               (212) 245-8800 Ext. 205
    516-482-8050                                      john@cameronassoc.com
    Richard@scarguard.com 


'/>"/>
SOURCE Scarguard Labs, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
2. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
3. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
4. Rohm and Haas Expands in India
5. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
6. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
7. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
8. Specialty Blades, Inc. Expands Management Team With New VP Engineering
9. CRH Medical expands Las Vegas operations
10. US Med-Equip Expands Corporate Support Center
11. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: